Stonegate Investment Group LLC Sells 17,285 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Stonegate Investment Group LLC lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 962,364 shares of the company's stock after selling 17,285 shares during the period. GE HealthCare Technologies accounts for 2.0% of Stonegate Investment Group LLC's portfolio, making the stock its 16th biggest holding. Stonegate Investment Group LLC owned about 0.21% of GE HealthCare Technologies worth $75,238,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. LGT Financial Advisors LLC raised its position in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth $31,000. Finally, Continuum Advisory LLC grew its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after acquiring an additional 168 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Insider Activity

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have recently commented on GEHC shares. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $96.00.

GE HealthCare Technologies Stock Down 1.5 %

Shares of NASDAQ GEHC traded down $1.30 during trading hours on Friday, hitting $88.25. The stock had a trading volume of 978,315 shares, compared to its average volume of 2,657,198. The company has a market capitalization of $40.32 billion, a P/E ratio of 24.24, a P/E/G ratio of 2.90 and a beta of 1.11. The firm's 50-day moving average price is $82.76 and its two-hundred day moving average price is $84.95. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a 52 week low of $72.52 and a 52 week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies's quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.99 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's payout ratio is currently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.